MDR1 RNA transcripts do not indicate long-term prognosis in colorectal carcinomas

European Journal of Cancer Part A

Volumn 33, Issue 9, 1997, Pages 1516-1518

  Zochbauer S ^a   Wallner, J ^a   Haider, K ^b   Depisch, D ^b   Huber, H ^a   Pirker, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Landesklinikum Wr Neustadt   (Austria)

Author keywords

Colorectal carcinoma; MDR1 genes P glycoprotein; Multidrug resistance; Prognosis; Survival

Indexed keywords

ARTICLE; CANCER SURVIVAL; COLORECTAL CARCINOMA; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOTHESIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; SURVIVAL RATE;

EID: 0343765815     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00139-1     Document Type: Article

References (15)

1. Pirker R, Wallner J, Gsur A, et al. MDR1 gene expression in primary colorectal carcinomas. Br J Cancer 1993, 68, 691-694.
2. Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and MDR gene expression in colorectal cancer. Cancer 1993, 71, 2454-2460.
3. Sinicrope FA, Hart J, Brasitus TA, Michelassi F, Lee J, Safa AR. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse. Cancer 1994, 74, 2908-2917.
4. Pastan I, Gottesman MM. Multiple-drug resistance in human cancer. N Engl J Med 1987, 316, 1388-1393.
5. Goldstein LJ, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989, 81, 116-124.
6. Weinstein RS, Jakate SM, Dominguez JM, et al. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 1991, 51, 2720-2726.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.
8. Baldini N, Scotlandi K, Barbanti-Brodano G, et al. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med 1995, 333, 1380-1385.
9. Chan HSL, Thorner PS, Haddad G, Ling V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990, 8, 689-704.
10. Pirker R, Wallner J, Geissler K, et al. MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 1991, 83, 708-712.
11. Marie JP, Zittoun R, Sikic BI. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1991, 78, 586-592.
12. Zöchbauer S, Gsur A, Brunner R, Kyrie PA, Lechner K, Pirker R. P-glycoprotein expession as unfavorable prognostic factor in acute myeloid leukemia. Leukemia 1994, 8, 974-977.
13. Chan HSL, Haddad G, Thorner PS, et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 1991, 325, 1608-1614.
14. Murray DN, Bordow SB, Marshall GM, Haber PS, Cohn SL, Haber M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 1996, 334, 231-238.
15. Filipits M, Suchomel RW, Dekan G, et al. Expression of the multidrug-resistance-associated protein (MRP) gene in colorectal carcinomas. Br J Cancer 1997, 75, 208-212.